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There would be no higher forms of human life on earth
without oxygen. Throughout existence our bodies have
relied on a constant and continuous supply of oxygen. In
circumstances where oxygen availability is reduced
(hypoxia), the inherent physiologic responses that are
initiated through both cellular as well as systemic
mechanisms are beginning to be understood. The very early
and fascinating studies that were performed over a century
ago had ‘‘volunteers’’ (read: adventurers) exposing them-
selves by climbing high mountains just to attain hypoxic
environmental conditions. At the beginning of the twentieth
century the only concern regarding hypoxia was related to
situations involving pulmonary disease, anemia and ascent
to high altitude. In the last 2 decades, however, the ever
increasing reach of hypoxia has become much more evi-
dent. Hypoxia plays a crucial role in almost all acute and
chronic diseases including, but not limited to, kidney and
liver diseases, pulmonary hypertension, most forms of
cardiovascular disease including atherosclerosis, stroke,
ischemic diseases, retinal degeneration, wound healing,
several pathologies of the CNS, inflammation, transplan-
tation, acute or chronic mountain sickness and—last but
not least—tumorigenesis. In addition to these pathological
conditions, reduced oxygenation occurs also under normal
physiologic circumstances, namely during embryonic
development, physical activity and ascent to high altitude.
On one hand the impact of hypoxia has attracted many
basic scientists into the field of oxygen sensing and
oxygen-dependent gene expression. This explosion of
enthusiasm has been very fruitful, and several mechanisms
of the molecular response to hypoxia have been unraveled.
On the other hand, many physiologists and clinical
researchers have focused on hypoxic adaptation and
acclimatization in exercising humans, including elite ath-
letes and extreme mountaineers. The time has come for the
basic researchers working in the field of molecular hypoxia
to come together with their colleagues who have been
examining the hypoxic response in human volunteers and
patients. The last few international ‘‘hypoxia’’ meetings
have successfully initiated the integration of these two
groups. One of those meetings—which I had the honor to
organize—was held for the second time at Monte Verita` in
Ascona, the Italian-speaking region of Switzerland, at the
end of 2007. At the ‘‘Mountain of Truth,’’ approximately
70 world-leading investigators in the molecular, physio-
logic and clinical fields of hypoxia met to discuss topics
ranging from translational aspects of integrative biology to
human disease. By this time, I was kindly asked by the
editors of CMLS to select a few ‘‘hypoxic’’ topics that
could be of interest for their widespread readership. I am
glad that most of the colleagues that I invited to share their
work enthusiastically agreed to contribute. The realization
of this multi-author review might have taken longer than
expected, but the present reviews are excellent, reader-
friendly and up to date.
Nature considers sufficient oxygen supply to each single
cell so important that all cells in our body are able to sense
oxygenation and respond to hypoxia within seconds to
minutes. Remarkably, every single cell constantly synthe-
sizes factors that are primarily stabilized only in the
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presence of hypoxia. Prominent among these factors are the
hypoxia-inducible factors (HIFs) that under normoxic
conditions are basically degraded immediately after being
synthesized. This is an energetic burden for the cell but
allows for an instantaneous response when oxygen supply is
reduced. Pugh and colleagues brilliantly summarize—with
their well-known British humor—the fascinating molecular
interplay between oxygen, HIFs and prolyl hydroxylases
(PHDs). Building upon this fundamental knowledge,
Antoniou and Ogunshola move from molecules directly to
Alzheimer’s patients, questioning whether hypoxically
induced HIF-1 stabilization mediates neurodegeneration.
What is the connection between low oxygenation and this
disease? The brain’s extreme sensitivity to hypoxia may
lead to severe alterations of the brain’s function by rapidly
disturbing neuronal homeostasis. Apart from Alzheimer’s,
hypoxia has been implicated in many more neurological
diseases such as Parkinson’s disease and stroke.
Every reader knows that trekking in the beautiful Alti-
plano at 3–4,000 m above sea level will make everyone
breathless in one way or another. Adequate oxygenation of
every single cell requires efficient oxygen uptake from the
air by the lungs. Even under physiological conditions, the
environmental oxygen supply might change and thus ven-
tilation must adapt accordingly. Joseph and Pequinot
explain in their review how ventilation acclimatizes in
response to such a hypoxic challenge. This acclimatization
requires a complex reorganization in both the peripheral
(carotid bodies) and the central (brainstem respiratory
groups) chemoreceptors. Once ventilation is elevated, the
oxygen uptake by the erythrocytes increases too. Soliz and
myself asked the question as to whether there is a HIF-target
gene that might regulate both the respiratory and the
hematopoietic response to hypoxia. Indeed, we show that
the ‘‘old blood hormone’’ erythropoietin (Epo) plays a
crucial role in ventilation by interacting with carotid bodies
(systemic Epo) as well as with the respiratory groups
(cerebrally produced Epo). Of note, during the last decade it
has become evident that Epo has far more functions apart
from enhancing red blood cell production, with most of
these functions associated with neuroprotection. As such,
Monge and colleagues present new insights in Epo’s pro-
tective role on auditory hair cells of the inner ear: Epo
reduced the gentamicin-induced hair cell damage.
Despite all the protective mechanisms we possess,
acclimatization to reduced oxygenation, such as that which
is experienced at high altitude, might fail. Typically, this
so-called acute mountain sickness (AMS) is observed in
mountaineers who ascend to high altitudes too rapidly.
Obviously, nature did not consider the use of cars, gon-
dolas, air transport or the top-end equipment that allow fast
ascent to the roofs of this world. AMS and the resulting
high altitude cerebral edema (HACE) are life-threatening,
as we will see in the very comprehensive review by Bailey
and colleagues. By applying diffusion-weighted magnetic
resonance imaging (MRI), they provide new insights into
the development of HACE.
What about your heart at altitude, especially if you plan
extensive physical activity? Highlanders are used to exer-
cise at high altitude and show, accordingly, advantages
over lowlanders who want to compete with them.
Remember the disputes concerning soccer games in La
Paz! Moreover, some athletes seek altitude training to
improve their competition performance. Calbet—definitely
a lowlander living on an island—and his colleagues
describe in their review the impact of acute and chronic
hypoxia on the heart’s function. This topic is followed by
an overview focusing on the exercising skeletal muscle at
hypoxia. Lundby and his athletic colleagues review the fact
that the working muscle becomes hypoxic already at sea
level and that oxygenation of the skeletal muscle is further
challenged by exercising at high altitude.
Hypoxia is everywhere. We constantly face physiolog-
ical or pathological hypoxic conditions whether it is
systemically, locally or at the cellular and molecular levels.
I am convinced that within the next few years the know-
ledge of hypoxic signaling pathways will enter common
clinical application. Most probably, hypoxic precondition-
ing of cells, organs (organ transplantation) and perhaps
even patients will be fashionable.
As you realize, the presented topics are fascinating and
more is to come! I deeply apologize for not having asked
all our participants for their interesting contributions, but I
do hope to have balanced the reviews as envisioned: from
molecules to men. Thank you all for your dedication to
‘‘hypoxic science.’’
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